Biowaiver of strengh in fixed combinatios [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2015-05-18 12:21 (4060 d 18:13 ago) – Posting: # 14848
Views: 3,224

Dear All,
I would like to follow up Averroe's post regarding the fulfillment of proportional composition condition for a generic fixed combination in order to biowaive the lower strenght(s). If you only change the amount of one drug and the other remains the same (10/20, 20/20, 40/20) the conditions regarding proportional composition cannot be fulfilled for all active substances of fixed combinations. If you consider the drug with the fixed strength (active substance is less than 5%)as an excipient it could be interpreted that proportional composition condition is fulfilled.
Could anybody, as per your experience, let me know how EMA regulatory authorities interprete this?
Kind regards and thanks in advance,
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
296 visitors (0 registered, 296 guests [including 26 identified bots]).
Forum time: 06:34 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5